Publications by authors named "A Klip"

Glucose is the universal fuel of most mammalian cells, and it is largely replenished through dietary intake. Glucose availability to tissues is paramount for the maintenance of homeostatic energetics and, hence, supply should match demand by the consuming organs. In its journey through the body, glucose encounters cellular barriers for transit at the levels of the absorbing intestinal epithelial wall, the renal epithelium mediating glucose reabsorption, and the tight capillary endothelia (especially in the brain).

View Article and Find Full Text PDF

Skeletal muscle insulin resistance, a major contributor to type 2 diabetes, is linked to the consumption of saturated fats. This insulin resistance arises from failure of insulin-induced translocation of glucose transporter type 4 (GLUT4; also known as SLC2A4) to the plasma membrane to facilitate glucose uptake into muscle. The mechanisms of defective GLUT4 translocation are poorly understood, limiting development of insulin-sensitizing therapies targeting muscle glucose uptake.

View Article and Find Full Text PDF

Elevated blood glucose following a meal is cleared by insulin-stimulated glucose entry into muscle and fat cells. The hormone increases the amount of the glucose transporter GLUT4 at the plasma membrane in these tissues at the expense of preformed intracellular pools. In addition, muscle contraction also increases glucose uptake via a gain in GLUT4 at the plasma membrane.

View Article and Find Full Text PDF
Article Synopsis
  • The molecular mechanisms involved in skeletal muscle glucose uptake offer a potential way to address insulin resistance, particularly in conditions like obesity, diabetes, and cancer.
  • Rho guanine dissociation inhibitor α (RhoGDIα) plays a critical role in regulating insulin sensitivity by inhibiting the Rho GTPase Rac1, which is crucial for glucose transporter GLUT4 translocation in muscle cells.
  • Increased levels of RhoGDIα in the muscle of insulin-resistant individuals suggest its significant impact on insulin sensitivity and overall glucose regulation, positioning it as a target for future pharmacological treatments.
View Article and Find Full Text PDF

The lymphatic circulation regulates transfer of tissue fluid and immune cells toward the venous circulation. While obesity impairs lymphatic vessel function, the contribution of lymphatic endothelial cells (LEC) to metabolic disease phenotypes is poorly understood. LEC of lymphatic microvessels are in direct contact with the interstitial fluid, whose composition changes during the development of obesity, markedly by increases in saturated fatty acids.

View Article and Find Full Text PDF